ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 648

Influenza A (H1N1) Virus Infection Triggers Severe Pulmonary Inflammation in Lupus-Prone Mice Following Viral Clearance

Samantha Slight-Webb1, Harini Bagavant1, Sherry Crowe1, Jourdan R. Anderson2 and Judith A. James3, 1Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK, 2Arthritis & Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK, 3Clinical Arthritis and Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Animal models, infection and systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Systemic Lupus Erythematosus - Animal Models

Session Type: Abstract Submissions (ACR)

Background/Purpose: Each year, up to one fifth of the United States population is infected with influenza virus. Although mortality rates are low, hundreds of thousands are hospitalized each year. Specific high risk groups, such as those with dysregulated immune systems, are in greater danger for complications from influenza. Further, infections are a common cause of hospitalizations and mortalities in patients with systemic lupus erythematosus (SLE). To understand the influenza immune response in SLE and the effect of infection on autoimmune disease in a controlled setting, we utilized the MRL-Fas(lpr) lupus-prone mouse model.

Methods: Female MRL-Fas(lpr) mice were infected with 200 EID50 influenza A virus PR/8/34 H1N1. Mice were weighed daily as a measurement of morbidity and viral burden was determined by quantitative RT-PCR of the influenza M1 gene. Further, lung, kidney, and spleen samples were collected at various time points post infection to analyze pathology by H&E and PAS staining, cytokines by ELISA, and cellular composition by flow cytometry. Total antigen-specific cells were determined by stimulated cells overnight with inactivated influenza virus and intracellular staining for cytokines. Serum was collected to determine autoantibody concentrations by ELISA.  Apoptosis was examined in the spleen on paraffin-embedded spleen sections by TUNEL staining. Finally, the role of extrinsic apoptosis in influenza infected lupus-prone mice was examined by administration of 0.1 mM caspase-8 inhibitor (Z-IETD-FMK) and negative control (Z-FA-FMK) daily for six days.  

Results: MRL-Fas(lpr) mice accumulated more CD8+ T cells and more TNF-a influenza A virus specific T cells with less neutrophil accumulation in the lung by day 7 post infection (P<0.05). Moreover, increased extrinsic apoptosis during influenza infection led to a reduction of autoimmune disease symptoms with decreased splenomegaly (P<0.0005) and kidney disease (P<0.05). Unlike acute infection, following clearance of the influenza A virus, MRL-Fas(lpr) mice had severe complications during the contraction and resolution phase with widespread severe pulmonary inflammation. Lupus-prone mice had an increased lung severity score (P<0.05) with significantly more CD4+ and CD8+ T cells and myeloid cells compared to MRL control mice at day 40 post infection (P<0.005). Further, the improvement of autoimmune disease symptoms ceased following clearance of the viral infection and by day 40 was similar to PBS treated MRL-Fas(lpr) mice.

Conclusion: Our findings suggest that autoimmunity drives an enhanced influenza-specific immune response to clear infection, but that severe complications can arise during the resolution of pulmonary inflammation. We propose that problems with pulmonary infection in lupus may arise not from an inadequate antigen-specific immune response, but from sustained pulmonary inflammation and defective cellular clearance causing prolonged symptoms in patients. Additionally, influenza infection diminishes autoimmune disease responses rather than exacerbate autoimmune pathology in mice during the acute infection as a direct result of virus induced apoptosis.


Disclosure:

S. Slight-Webb,
None;

H. Bagavant,
None;

S. Crowe,
None;

J. R. Anderson,
None;

J. A. James,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/influenza-a-h1n1-virus-infection-triggers-severe-pulmonary-inflammation-in-lupus-prone-mice-following-viral-clearance/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology